0.00Open0.10Pre Close0 Volume52 Open Interest2.50Strike Price0.00Turnover180.64%IV43.53%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type-0.0862Delta0.0769Gamma42.50Leverage Ratio-0.0062Theta-0.0003Rho-3.66Eff Leverage0.0018Vega
Autolus Therapeutics Stock Discussion
Abeona Therapeutics ( $Abeona Therapeutics(ABEO.US)$ )
Asset: Pz-cel (prademagene zamikeracel)
PDUFA Date: May 25, 2024
Indication: Recessive dystrophic epidermolysis bullosa (RDEB)
Technology: Autologous cell therapy, treatment uses gene transfer to deliver COL7A1 genes into an RDEB patient’s own skin cells then transplanting them back to the patient.
Rocket Pharmaceuticals ( $Rocket Pharmaceuticals(RCKT.US)$ ) ...
Pre-market Magic: Wanna know the insider scoop before the market opens? Our talented crew will give you the lowdown on pre-market movements, giving you a sneak peek into the thrill of investing!
FDA Calendar Know-how: Confused about FDA approval processes? Fear not! Our FDA Calendar will turn you into a pharma whiz, keeping you in the loop with crucial timings!
Money Trail: Curious about where the funds are flowing? The Fundraising Tracker '23 is here to spill the beans, ...
$Autolus Therapeutics(AUTL.US)$
$Bright Minds Biosciences(DRUG.US)$
No comment yet